Single-Cell Omics 2019
DOI: 10.1016/b978-0-12-817532-3.00008-6
|View full text |Cite
|
Sign up to set email alerts
|

Single-Cell Omics in Metabolic Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…The risk haplotype increased the presence of a less adherent, less contractile phenotype within a VSMC population, but phenotype penetrance was variable; heterogeneous expression of specific isoforms of an lncRNA, which could potentially exacerbate CAD and was especially apparent when populations were sorted, could drive the variability that we observed in the lines across and within patients. Although we focused specifically on the 9p21 locus, the majority of disease-associated SNPs are in noncoding loci, and thus, it is important to recognize that some of the heterogeneity observed in disease progression ( 41 43 ) could be due to this. We believe that our findings are supportive of a general approach to exploring mechanisms by which noncoding loci enhance risk for disease and in which cellular heterogeneity is a hallmark.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The risk haplotype increased the presence of a less adherent, less contractile phenotype within a VSMC population, but phenotype penetrance was variable; heterogeneous expression of specific isoforms of an lncRNA, which could potentially exacerbate CAD and was especially apparent when populations were sorted, could drive the variability that we observed in the lines across and within patients. Although we focused specifically on the 9p21 locus, the majority of disease-associated SNPs are in noncoding loci, and thus, it is important to recognize that some of the heterogeneity observed in disease progression ( 41 43 ) could be due to this. We believe that our findings are supportive of a general approach to exploring mechanisms by which noncoding loci enhance risk for disease and in which cellular heterogeneity is a hallmark.…”
Section: Discussionmentioning
confidence: 99%
“…While adhesion sorting is not novel, it has primarily been used to study cancer ( 47 ) or sort rare populations from blood, such as circulating tumor cells ( 48 50 ) or stem cells ( 51 ). Many diseases, including CAD, progress through the development of divergent behaviors within a cell type ( 41 43 , 52 ); thus, application of biophysical sorting has the potential to unveil key insights where other methods cannot. For example, we found that adhesion-based sorting of VSMCs allowed us to isolate subpopulations of weakly and strongly adherent phenotypes and directly compare them to better assess phenotype plasticity.…”
Section: Discussionmentioning
confidence: 99%